NCT06445322

Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials

Study Summary

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.

Want to learn more about this trial?

Request More Info

Interventions

Prescreening AssessmentsDIAGNOSTIC_TEST
Various genetic and visual assessments.

Study Locations

FacilityCityStateCountry
University of San FranciscoSan FranciscoCaliforniaUnited States
Vitreo Retinal AssociatesGainesvilleFloridaUnited States
Wilmer Eye Institute at John HopkinsBaltimoreMarylandUnited States
Massachusetts Eye and EarBostonMassachusettsUnited States
University of Michigan Kellogg Eye CenterAnn ArborMichiganUnited States
Cincinnati Eye InstituteCincinnatiOhioUnited States
Retina Foundation of TexasDallasTexasUnited States
Retina Consultants of TexasHoustonTexasUnited States

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026